Skip to content

Author

Xue-Ling Chen

We have 1 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Integrative multi-omics profiling reveals DRG1 promotes hepatocellular carcinoma via c-Myc phosphorylation and facilitates lenvatinib resistance.

The findings identify DRG1 as a potential prognostic biomarker and therapeutic target in HCC and identify its underlying regulatory mechanisms as a potential strategy to improve lenvatinib response.

Peng Wang, Jun-Ying Xu, Hao Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.